Stockreport

Monopar Announces CFO Succession

Monopar Therapeutics Inc.  (MNPR) 
PDF WILMETTE, Ill., May 24, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharmaceutical company focused on developing innovativ [Read more]